Repetitive Negative ThinkingNCT07513766
Emotion Regulation in RNT
An observational study of Repetitive Negative Thinking and Healthy Controls Group - Age and Sex-matched, run by University Hospital, Ghent at 1 site in Belgium.
Trial summary
The goal of this study is to understand why some people become stuck in repetitive negative thinking, which is common among individuals with depression and anxiety. Repetitive negative thinking involves repeatedly focusing on negative events, worries, or problems. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Repetitive Negative Thinking, Healthy Controls Group - Age and Sex-matched
- How many people
- 100 participants
- Where
- 1 siteBelgium
- Study dates
- 5 Jun 2024to 30 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Patient group mainly consists of individuals diagnosed with depression or generalized anxiety disorder (GAD).
Who may be able to join
- Patient group: diagnosis of depression/GAD
- Healthy control group: no history of or current form of psychopathology
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Belgium1 site, 1 recruiting
- Recruiting
University Hospital Ghent, Ghent, East-Flanders 9000
Ghent, 9000
Chris Baeken, +32476209841, Chris.Baeken@ugent.be
Sara De Witte
About this study
Official title: The Neural Mechanisms of Emotion Dysregulation in Repetitive Negative Thinking (RNT) Patients: A Pilot Study
The goal of this study is to understand why some people become stuck in repetitive negative thinking, which is common among individuals with depression and anxiety. Repetitive negative thinking involves repeatedly focusing on negative events, worries, or problems. These thoughts can be difficult to control and may worsen emotional distress and daily functioning.
Researchers believe that repetitive negative thinking may be related to changes in how different brain networks communicate with each other. This study will examine how the brain responds during emotion regulation tasks in people who tend to ruminate compared with healthy individuals.
Read more
To do this, researchers will use a brain-imaging technique called functional near-infrared spectroscopy (fNIRS). This method measures brain activity using harmless infrared light while participants perform tasks on a computer.
The main questions this study aims to answer are:
How does the brain respond to emotional situations in people who experience repetitive negative thinking?
Are there differences in brain activity between people with depression or anxiety and healthy individuals during emotion regulation?
Participants will include 50 healthy volunteers and 50 individuals with depression or anxiety who experience repetitive negative thinking.
Participants will:
Wear a lightweight brain-imaging device (fNIRS) placed on the head to measure brain activity
Complete computer tasks involving emotional images and different emotion-regulation strategies, such as reinterpreting, suppressing, or distracting from emotions
Listen to different types of spoken feedback (criticism, praise, or neutral comments) and imagine receiving them from someone they know
Report their emotional feelings during the tasks
Complete several questionnaires about mood, thinking patterns, and emotional experiences
During the experiment, researchers will also record physiological responses such as heart activity and skin reactions, which are related to emotional responses.
The results of this study may help researchers better understand the brain mechanisms underlying rumination and may contribute to the development of more effective treatments for depression and anxiety.
Read the detailed description
Repetitive negative thinking (RNT), also known as rumination, is a key aspect of both depression and generalized anxiety disorder (GAD). RNT involves a pattern of repeated and uncontrollable negative thinking, often leaving individuals feeling trapped in a cycle of worrisome thoughts and gloomy ruminations. These cognitive processes can significantly impact both the emotional state and daily functioning of those suffering from it. In depression, RNT is often associated with constant rumination on negative events, past mistakes, and feelings of hopelessness. This repetitive and negative thinking often reinforces feelings of despondency and can further depress mood. In GAD, RNT manifests as persistent worry about numerous potential future dangers and problems, even when the actual threat is minimal.
RNT is considered an underlying mechanism involved in several psychiatric disorders. RNT not only amplifies the intensity of negative emotions but can also contribute to the duration and severity of psychological symptoms. Addressing RNT is increasingly recognized as a crucial target for both future research and clinical interventions. By better understanding the complex relationship between rumination and mental health disorders, we can not only elucidate the onset and progression of these disorders but also develop more targeted treatments aimed at disrupting the negative thinking patterns that characterize RNT.
Research has demonstrated abnormal neuronal activity in people with depression or GAD who also experience RNT. Previous studies using functional magnetic resonance imaging (fMRI) have demonstrated atypical functional connectivity (FC) and brain activity in specific regions of the Central Executive Network (CEN), the default mode network (DMN), and the Salience Network (SN) during computer-based tasks measuring emotion regulation in individuals with depression and GAD, compared to healthy controls.
For this reason, the focus of our research is on identifying the specific neural, cognitive, and emotional mechanisms that fuel and maintain rumination.
A promising approach for this research is Functional Near-Infrared Spectroscopy (fNIRS), an optical brain imaging technique that uses infrared light for functional neuroimaging. fNIRS measures brain activity by detecting shifts in the concentrations of oxidized and deoxidized hemoglobin, making it one of the most widely used non-invasive neuroimaging methods with remarkable temporal resolution. The primary goal of this study is to investigate differential brain responses during emotion regulation tasks in patients with RNT compared to healthy controls using fNIRS.
The research group will include both healthy controls (n = 50) and individuals with depression and anxiety who exhibit tendencies toward RNT (n = 50). The fNIRS device will be placed on the participants' heads to record brain activity, while two experimental paradigms will be used simultaneously to investigate emotion regulation: 1) Emotion Regulation Task; 2) Criticism Paradigm.
The Emotion Regulation Task initially involves two conditions: simple presentation of neutral images ("neutral viewing") and simple presentation of negative images ("negative viewing"). These conditions are presented sequentially, with the goal of measuring the engagement of the cognitive control network during emotional responses. Participants receive on-screen prompts before beginning each task in each condition. At this stage, a "Look" prompt is presented, asking participants to notice their feelings toward the neutral or negative image and respond naturally. At the end of each trial, participants are asked to rate their emotions at that moment. Additionally, the study includes three emotion regulation conditions, randomly assigned to each participant: positive reappraisal of negative images ("positive reappraisal"), suppression of feelings toward negative images ("suppression"), and distraction from negative images ("distraction"). For the "Reappraisal" prompt, participants are asked to reinterpret aversive images by creating a story to make the images less negative or even more positive. In the "Distraction" prompt, participants are asked to quickly determine whether a given mathematical equation hovering over negative images is correct or incorrect by pressing a button. In the "Suppression" prompt, , participants are expected to suppress their emotions regarding the image.
The Criticism paradigm involves participants listening to a series of auditory comments while focusing their gaze on a fixation cross displayed on a computer screen. These comments comprise three emotional tones: negative (criticism), positive (praise), and neutral. Each comment lasts 30 seconds and is alternated with 30 seconds of silence. All participants are exposed to the same comments and instructed to imagine that they are listening to someone who knows them very well. This section begins with two neutral comments, followed by two positive comments, and concludes with another two neutral comments followed by two negative comments.
Resting-state measurements are also performed before and after the emotion regulation task and the criticism paradigm.
Resting-state measurements are also performed before and after the emotion regulation task and the criticism paradigm.
During the computer task and resting state measurement, we collect physiological data regarding heart and skin functions. This includes measuring heart rate (ECG), cardiac activity (ICG), and skin reactions (SCR). These physiological measurements are linked to emotion regulation.
In addition, participants' behavioral measurements are assessed using various questionnaires, including demographic data, MINI-screening, HDRS (for patients only), PC, VAS-emotion, MAIA, BDI, STAI, PSWQ, LARSS, RRS, CERQ, PTQ, self-critical rumination.
- Keywords
- Repetitive negative thinking, fnirs, emotion regulation
- Medical subject headings
- Emotional Regulation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Patient group | People who have a current or past history of anxiety and/or depression | |
| Healthy control group | People who do not have a current or past history of anxiety and/or depression |
What is being measured
The primary outcome is the main question the study is designed to answer.
Perseverative Thinking Questionnaire (PTQ) total score
The Perseverative Thinking Questionnaire (PTQ) total score will be used to assess repetitive negative thinking at baseline. Baseline PTQ total scores will be compared between patients and healthy controls.
Measured: During a single laboratory session (baseline assessment)
Penn State Worry Questionnaire (PSWQ) score
The Penn State Worry Questionnaire (PSWQ) total score will be used to assess worry at baseline. Baseline PSWQ total scores will be compared between patients and healthy controls
Measured: During a single laboratory session (baseline assessment)
Leuven Adaptation of the Rumination on Sadness Scale (LARSS) score
The Leuven Adaptation of the Rumination on Sadness Scale (LARSS) score will be used to assess rumination at baseline. Baseline LARSS total scores will be compared between patients and healthy controls.
Measured: During a single laboratory session (baseline assessment)
Ruminative Responses Scale (RRS) score
The Ruminative Responses Scale (RRS) score will be used to assess rumination at baseline. Baseline RRS total scores will be compared between patients and healthy controls.
Measured: During a single laboratory session (baseline assessment)
Secondary outcomes (5)
Mean task-evoked oxygenated hemoglobin (HbO) changes in cortical regions-mainly the dorsolateral prefrontal cortex and precuneus-during the emotion regulation task, as measured by fNIRS.
Functional near-infrared spectroscopy (fNIRS) will be used to measure task-evoked changes in oxygenated (HbO), deoxygenated (HbR), and total hemoglobin (HbT) in predefined prefrontal cortical regions during the emotion regulation task. For each participant, mean HbO, HbR, and HbT changes will be calculated across task blocks and compared between patients and healthy controls at baseline.
Measured: During a single laboratory session (baseline assessment)
Mean task-evoked oxygenated hemoglobin (HbO) change in prefrontal cortical regions during the critical paradigm measured by fNIRS
Functional near-infrared spectroscopy (fNIRS) will be used to measure task-evoked changes in oxygenated hemoglobin (HbO) in predefined prefrontal cortical regions during the critical paradigm. For each participant, mean HbO changes will be calculated across task blocks and compared between patients and healthy controls at baseline.
Measured: During a single laboratory session (baseline assessment)
Mean resting-state functional connectivity in prefrontal cortical regions measured by fNIRS
Resting-state functional near-infrared spectroscopy (fNIRS) data will be used to assess functional connectivity in predefined prefrontal cortical regions. For each participant, mean resting-state functional connectivity values will be calculated from resting-state recordings and compared between patients and healthy controls at baseline.
Measured: During a single laboratory session (baseline assessment)
Mean heart rate during experimental tasks measured by electrocardiography (ECG)
Electrocardiography (ECG) will be used to assess heart rate during the experimental tasks. For each participant, mean heart rate will be calculated across task periods and compared between patients and healthy controls at baseline.
Measured: During a single laboratory session (baseline assessment)
Mean skin conductance response amplitude during experimental tasks measured by skin conductance recording (SCR)
Skin conductance recording (SCR) will be used to assess autonomic arousal during the experimental tasks. For each participant, mean skin conductance response amplitude will be calculated across task periods and compared between patients and healthy controls at baseline.
Measured: During a single laboratory session (baseline assessment)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Apr 2026
- Study start5 Jun 2024
- Primary completion30 Mar 2026 (estimated)
- Study completion30 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for Repetitive Negative ThinkingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Ghent
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Chris Baeken, Principal investigator, University Ghent
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07513766
- Sponsor's protocol ID
- ONZ-2023-0459
- Status last verified
- Mar 2026
- First submitted
- 19 Mar 2026
- Last updated
- 7 Apr 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Morawetz C, Riedel MC, Salo T, Berboth S, Eickhoff SB, Laird AR, Kohn N. Multiple large-scale neural networks underlying emotion regulation. Neurosci Biobehav Rev. 2020 Sep;116:382-395. doi: 10.1016/j.neubiorev.2020.07.001. Epub 2020 Jul 11.
PubMed 32659287Fitzgerald JM, Klumpp H, Langenecker S, Phan KL. Transdiagnostic neural correlates of volitional emotion regulation in anxiety and depression. Depress Anxiety. 2019 May;36(5):453-464. doi: 10.1002/da.22859. Epub 2018 Nov 8.
PubMed 30408261Demichelis OP, Grainger SA, Hubbard RE, Henry JD. Emotion regulation mediates the relationship between social frailty and stress, anxiety, and depression. Sci Rep. 2023 Apr 20;13(1):6430. doi: 10.1038/s41598-023-33749-0.
PubMed 37081078Watkins ER, Roberts H. Reflecting on rumination: Consequences, causes, mechanisms and treatment of rumination. Behav Res Ther. 2020 Apr;127:103573. doi: 10.1016/j.brat.2020.103573. Epub 2020 Jan 31.
PubMed 32087393Spinhoven P, van Hemert AM, Penninx BW. Repetitive negative thinking as a predictor of depression and anxiety: A longitudinal cohort study. J Affect Disord. 2018 Dec 1;241:216-225. doi: 10.1016/j.jad.2018.08.037. Epub 2018 Aug 10.
PubMed 30138805
Study at a glance
From the registry record, last updated by the sponsor on 7 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Neural Mechanisms of Emotion Dysregulation in Repetitive Negative Thinking (RNT) Patients: A Pilot Study
- ClinicalTrials.gov ID
- NCT07513766
- Acronym / sponsor ID
- ONZ-2023-0459
- Keywords
- Repetitive negative thinking, fnirs, emotion regulation
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- University Hospital, GhentUniversity, hospital or other
- Study start
- 5 Jun 2024 (actual)
- Primary completion
- 30 Mar 2026 (estimated)
- Study completion
- 30 Dec 2026 (estimated)
- First posted
- 7 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to understand why some people become stuck in repetitive negative thinking, which is common among individuals with depression and anxiety. Repetitive negative thinking involves repeatedly focusing on negative events, worries, or problems. These thoughts can be difficult to control and may worsen emotional distress and daily functioning.
Researchers believe that repetitive negative thinking may be related to changes in how different brain networks communicate with each other. This study will examine how the brain responds during emotion regulation tasks in people who tend to ruminate compared with healthy individuals.
To do this, researchers will use a brain-imaging technique called functional near-infrared spectroscopy (fNIRS). This method measures brain activity using harmless infrared light while participants perform tasks on a computer.
The main questions this study aims to answer are:
How does the brain respond to emotional situations in people who experience repetitive negative thinking?
Are there differences in brain activity between people with depression or anxiety and healthy individuals during emotion regulation?
Participants will include 50 healthy volunteers and 50 individuals with depression or anxiety who experience repetitive negative thinking.
Participants will:
Wear a lightweight brain-imaging device (fNIRS) placed on the head to measure brain activity
Complete computer tasks involving emotional images and different emotion-regulation strategies, such as reinterpreting, suppressing, or distracting from emotions
Listen to different types of spoken feedback (criticism, praise, or neutral comments) and imagine receiving them from someone they know
Report their emotional feelings during the tasks
Complete several questionnaires about mood, thinking patterns, and emotional experiences
During the experiment, researchers will also record physiological responses such as heart activity and skin reactions, which are related to emotional responses.
The results of this study may help researchers better understand the brain mechanisms underlying rumination and may contribute to the development of more effective treatments for depression and anxiety.
Detailed description
Repetitive negative thinking (RNT), also known as rumination, is a key aspect of both depression and generalized anxiety disorder (GAD). RNT involves a pattern of repeated and uncontrollable negative thinking, often leaving individuals feeling trapped in a cycle of worrisome thoughts and gloomy ruminations. These cognitive processes can significantly impact both the emotional state and daily functioning of those suffering from it. In depression, RNT is often associated with constant rumination on negative events, past mistakes, and feelings of hopelessness. This repetitive and negative thinking often reinforces feelings of despondency and can further depress mood. In GAD, RNT manifests as persistent worry about numerous potential future dangers and problems, even when the actual threat is minimal.
RNT is considered an underlying mechanism involved in several psychiatric disorders. RNT not only amplifies the intensity of negative emotions but can also contribute to the duration and severity of psychological symptoms. Addressing RNT is increasingly recognized as a crucial target for both future research and clinical interventions. By better understanding the complex relationship between rumination and mental health disorders, we can not only elucidate the onset and progression of these disorders but also develop more targeted treatments aimed at disrupting the negative thinking patterns that characterize RNT.
Research has demonstrated abnormal neuronal activity in people with depression or GAD who also experience RNT. Previous studies using functional magnetic resonance imaging (fMRI) have demonstrated atypical functional connectivity (FC) and brain activity in specific regions of the Central Executive Network (CEN), the default mode network (DMN), and the Salience Network (SN) during computer-based tasks measuring emotion regulation in individuals with depression and GAD, compared to healthy controls.
For this reason, the focus of our research is on identifying the specific neural, cognitive, and emotional mechanisms that fuel and maintain rumination.
A promising approach for this research is Functional Near-Infrared Spectroscopy (fNIRS), an optical brain imaging technique that uses infrared light for functional neuroimaging. fNIRS measures brain activity by detecting shifts in the concentrations of oxidized and deoxidized hemoglobin, making it one of the most widely used non-invasive neuroimaging methods with remarkable temporal resolution. The primary goal of this study is to investigate differential brain responses during emotion regulation tasks in patients with RNT compared to healthy controls using fNIRS.
The research group will include both healthy controls (n = 50) and individuals with depression and anxiety who exhibit tendencies toward RNT (n = 50). The fNIRS device will be placed on the participants' heads to record brain activity, while two experimental paradigms will be used simultaneously to investigate emotion regulation: 1) Emotion Regulation Task; 2) Criticism Paradigm.
The Emotion Regulation Task initially involves two conditions: simple presentation of neutral images ("neutral viewing") and simple presentation of negative images ("negative viewing"). These conditions are presented sequentially, with the goal of measuring the engagement of the cognitive control network during emotional responses. Participants receive on-screen prompts before beginning each task in each condition. At this stage, a "Look" prompt is presented, asking participants to notice their feelings toward the neutral or negative image and respond naturally. At the end of each trial, participants are asked to rate their emotions at that moment. Additionally, the study includes three emotion regulation conditions, randomly assigned to each participant: positive reappraisal of negative images ("positive reappraisal"), suppression of feelings toward negative images ("suppression"), and distraction from negative images ("distraction"). For the "Reappraisal" prompt, participants are asked to reinterpret aversive images by creating a story to make the images less negative or even more positive. In the "Distraction" prompt, participants are asked to quickly determine whether a given mathematical equation hovering over negative images is correct or incorrect by pressing a button. In the "Suppression" prompt, , participants are expected to suppress their emotions regarding the image.
The Criticism paradigm involves participants listening to a series of auditory comments while focusing their gaze on a fixation cross displayed on a computer screen. These comments comprise three emotional tones: negative (criticism), positive (praise), and neutral. Each comment lasts 30 seconds and is alternated with 30 seconds of silence. All participants are exposed to the same comments and instructed to imagine that they are listening to someone who knows them very well. This section begins with two neutral comments, followed by two positive comments, and concludes with another two neutral comments followed by two negative comments.
Resting-state measurements are also performed before and after the emotion regulation task and the criticism paradigm.
Resting-state measurements are also performed before and after the emotion regulation task and the criticism paradigm.
During the computer task and resting state measurement, we collect physiological data regarding heart and skin functions. This includes measuring heart rate (ECG), cardiac activity (ICG), and skin reactions (SCR). These physiological measurements are linked to emotion regulation.
In addition, participants' behavioral measurements are assessed using various questionnaires, including demographic data, MINI-screening, HDRS (for patients only), PC, VAS-emotion, MAIA, BDI, STAI, PSWQ, LARSS, RRS, CERQ, PTQ, self-critical rumination.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Patient group | – | –People who have a current or past history of anxiety and/or depression |
| Healthy control group | – | –People who do not have a current or past history of anxiety and/or depression |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Patient group mainly consists of individuals diagnosed with depression or generalized anxiety disorder (GAD).
Key inclusion criteria (2 listed)
- Patient group: diagnosis of depression/GAD
- Healthy control group: no history of or current form of psychopathology
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Perseverative Thinking Questionnaire (PTQ) total score
Time frame: During a single laboratory session (baseline assessment)
The Perseverative Thinking Questionnaire (PTQ) total score will be used to assess repetitive negative thinking at baseline. Baseline PTQ total scores will be compared between patients and healthy controls.
Penn State Worry Questionnaire (PSWQ) score
Time frame: During a single laboratory session (baseline assessment)
The Penn State Worry Questionnaire (PSWQ) total score will be used to assess worry at baseline. Baseline PSWQ total scores will be compared between patients and healthy controls
Leuven Adaptation of the Rumination on Sadness Scale (LARSS) score
Time frame: During a single laboratory session (baseline assessment)
The Leuven Adaptation of the Rumination on Sadness Scale (LARSS) score will be used to assess rumination at baseline. Baseline LARSS total scores will be compared between patients and healthy controls.
Ruminative Responses Scale (RRS) score
Time frame: During a single laboratory session (baseline assessment)
The Ruminative Responses Scale (RRS) score will be used to assess rumination at baseline. Baseline RRS total scores will be compared between patients and healthy controls.
5 secondary outcomes
Mean task-evoked oxygenated hemoglobin (HbO) changes in cortical regions-mainly the dorsolateral prefrontal cortex and precuneus-during the emotion regulation task, as measured by fNIRS.
Time frame: During a single laboratory session (baseline assessment)
Mean task-evoked oxygenated hemoglobin (HbO) change in prefrontal cortical regions during the critical paradigm measured by fNIRS
Time frame: During a single laboratory session (baseline assessment)
Mean resting-state functional connectivity in prefrontal cortical regions measured by fNIRS
Time frame: During a single laboratory session (baseline assessment)
Mean heart rate during experimental tasks measured by electrocardiography (ECG)
Time frame: During a single laboratory session (baseline assessment)
Mean skin conductance response amplitude during experimental tasks measured by skin conductance recording (SCR)
Time frame: During a single laboratory session (baseline assessment)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Apr 2026.
- Background: PubMed 32659287Morawetz C, Riedel MC, Salo T, Berboth S, Eickhoff SB, Laird AR, Kohn N. Multiple large-scale neural networks underlying emotion regulation. Neurosci Biobehav Rev. 2020 Sep;116:382-395. doi: 10.1016/j.neubiorev.2020.07.001. Epub 2020 Jul 11.
- Background: PubMed 30408261Fitzgerald JM, Klumpp H, Langenecker S, Phan KL. Transdiagnostic neural correlates of volitional emotion regulation in anxiety and depression. Depress Anxiety. 2019 May;36(5):453-464. doi: 10.1002/da.22859. Epub 2018 Nov 8.
- Background: PubMed 37081078Demichelis OP, Grainger SA, Hubbard RE, Henry JD. Emotion regulation mediates the relationship between social frailty and stress, anxiety, and depression. Sci Rep. 2023 Apr 20;13(1):6430. doi: 10.1038/s41598-023-33749-0.
- Background: PubMed 32087393Watkins ER, Roberts H. Reflecting on rumination: Consequences, causes, mechanisms and treatment of rumination. Behav Res Ther. 2020 Apr;127:103573. doi: 10.1016/j.brat.2020.103573. Epub 2020 Jan 31.
- Background: PubMed 30138805Spinhoven P, van Hemert AM, Penninx BW. Repetitive negative thinking as a predictor of depression and anxiety: A longitudinal cohort study. J Affect Disord. 2018 Dec 1;241:216-225. doi: 10.1016/j.jad.2018.08.037. Epub 2018 Aug 10.
- Individual participant dataSharing planned: No
Related trials for Repetitive Negative Thinking
Recruiting
Effect of Mindfulness-based Neurofeedback for Adolescents With Elevated Repetitive Negative Thinking
Repetitive Negative Thinking, Neurofeedback
Not yet recruiting
Calming Minds Study
Anxiety, Anxiety Depression
Recruiting
Group-Based Acceptance and Commitment Therapy Versus Active Control in University Students With Emotional Symptoms
Depression, Anxiety
Not yet recruiting
Mindfulness-based Neurofeedback to Reduce Negative Thinking in CHARMS Adolescents
Repetitive Negative Thinking, Serious Mental Illness Symptoms
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Chris Baeken principal investigator
University Ghent
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Repetitive Negative Thinking and Healthy Controls Group - Age and Sex-matched, run by University Hospital, Ghent at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 7 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Chris Baeken (+32476209841, Chris.Baeken@ugent.be), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Perseverative Thinking Questionnaire (PTQ) total score (time frame: During a single laboratory session (baseline assessment)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07513766, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2026.